Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kwangdong Won Tang is an approved herbal medicinal product developed by Kwangdong Pharmaceutical, specifically formulated to treat inflammation and pain associated with the common cold. It is a liquid oral solution based on the traditional Korean medicine (Hanbang) formula known as Galgeun-tang. The product contains a standardized mixture of herbal extracts, including Pueraria Root, Ephedra Herb, and Cinnamon Twig, which provide synergistic antipyretic, analgesic, and anti-inflammatory activities. Its mechanism of action involves the modulation of the sympathetic nervous system via adrenergic receptors and the inhibition of inflammatory mediators such as prostaglandins. Kwangdong Won Tang is a widely recognized over-the-counter treatment in South Korea for early-stage viral infections and associated musculoskeletal discomfort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kwangdong Won Tang.